Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid. - Wikidata - awgldk - TriplyDB

Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.

Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.

http://www.wikidata.org/entity/Q40479856

about

Natural Killer Cells for Therapy of Leukemia Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation NKG2D ligands as therapeutic targets Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest.Lenalidomide induces immunomodulation in chronic lymphocytic leukemia and enhances antitumor immune responses mediated by NK and CD4 T cells.Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.Transcriptional regulation of ULBP1, a human ligand of the NKG2D receptor.Plasticity of γδ T Cells: Impact on the Anti-Tumor Response Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas.CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.Ectopically expressed human tumor biomarker MutS homologue 2 is a novel endogenous ligand that is recognized by human γδ T cells to induce innate anti-tumor/virus immunity.Enhancement of fludarabine sensitivity by all-trans-retinoic acid in chronic lymphocytic leukemia cells.Complex role of γδ T-cell-derived cytokines and growth factors in cancer.A new effect of IL-4 on human γδ T cells: promoting regulatory Vδ1 T cells via IL-10 production and inhibiting function of Vδ2 T cells Regulation of ligands for the activating receptor NKG2D.NK cell receptors and their ligands in leukemia.DNA methylation in nasal epithelial cells from smokers: identification of ULBP3-related effects.NKG2D ligands in tumor immunity.Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.TCRγ4δ1-engineered αβT cells exhibit effective antitumor activity Human γδT-cell subsets and their involvement in tumor immunity.Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity.γδ T cell receptor ligands and modes of antigen recognition Targeting NKG2D in tumor surveillance.Hematological malignancies escape from NK cell innate immune surveillance: mechanisms and therapeutic implications.At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Targeting gamma delta T cells for cancer immunotherapy: bench to bedside.Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field?γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy.Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment.γδ T cells in cancer.Exploiting natural killer group 2D receptors for CAR T-cell therapy.γδT Cells and Related Diseases.Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor Vδ 2 T lymphocytes in non-Hodgkin lymphomas.Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy.Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells.

P2860

Q26745906-00C3B47E-7E3E-47B3-A479-BC74CB2B6468 Q26863724-28878790-881D-4744-89B7-D28ACBD1880F Q27014888-BEEDF191-6781-4734-9999-465FF6EA5656 Q28287583-310BF4F2-AEEC-4AB0-BCE2-7B0010842F84 Q30410836-73548A6B-BDCF-4491-9385-F138E0C7C6BD Q34278096-8BC502FE-5E18-43E8-BA8B-2268007CDE32 Q34294166-3213654B-13D7-43F3-A62B-A6DEA4757331 Q34556241-7C13FAE3-A5E6-4382-A958-D3FB12BD50C0 Q34652408-E0FCB4B1-A015-4C7E-BB36-CE3CE2BC0CC9 Q34668723-5E882F43-D7E5-4324-B843-864F1FE5178D Q34946005-E004F517-E7EC-4296-8DB6-341F51733A7C Q35956512-8A57C486-5C3F-4400-BBE8-54D4CA1EF533 Q36006445-A0E53875-60C1-4362-9F99-25CDBFB51D52 Q36444174-377589B1-11F8-4D6B-A1B2-594EB7136626 Q36674426-F3C7F566-6E06-4054-8B3C-B952FB167623 Q36872056-5E3C7CDF-8ACC-4D1B-A1FC-CFF19B2E2201 Q37018656-BD1A8A31-F668-4716-AF39-C764DBE42724 Q37147102-F6B66543-6721-4BC1-B89F-FE764AC7536A Q37287179-2B957B85-89CF-4781-BA34-8CEE5A1A1C40 Q37344951-E52461A0-491C-46AD-B5C6-FE9892C1F1FF Q37370559-1C8F4E7F-5505-43CA-834C-3A161BED5987 Q37714642-D3D9B9AE-5AB0-4499-9713-F801C1B39535 Q37729133-17F22BEC-E6FF-4F6A-8F9E-9D654EC65F0D Q37779043-D06A658E-3D78-4E24-994D-8995999AAC1A Q37836561-07992CC9-3715-4391-AE7B-F4A8C67101FC Q38005176-22F6071F-06BE-4F5E-A80F-E320D1A5CDC0 Q38035301-50C1D562-2764-445C-BAC5-3E11DAF9F9A3 Q38151057-1F62ECBE-9CBF-47F7-AC15-54FD9FD0EC22 Q38179172-EF668422-785E-40EF-B7BE-3D1FF3758804 Q38217512-A5A82D19-085C-4DF3-9F2D-4B9F857AA62D Q38271585-8A7029F3-9A7F-4E90-BD8C-F73F7C1BF47E Q38287973-A1C0646B-545A-4D46-813E-D45239F031B9 Q38602555-8912B310-1FFD-4ACC-9A6C-70B5965729B4 Q38671184-9BA825CB-3A28-471A-956B-8A2E8DC414FC Q38718920-42A1F956-5092-443C-8728-4919B379AD38 Q39158802-D709DACA-0C00-408C-8734-E235ACCAD16F Q39396311-B9E82CBB-70EC-4FA9-9009-C95BF6838E92 Q39593994-F86F996C-37EC-405C-B05A-6543048C2CCF Q40106388-BC8C607D-D25D-44A4-BADC-35F2F33CD793 Q40108262-CB462B9E-CBEE-46F5-8C4E-BDD157715D25

P2860

Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.

http://www.wikidata.org/entity/Q40479856

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Vdelta1 T lymphocytes from B-C ...... ulated by trans-retinoic acid.

@en

type

label

Vdelta1 T lymphocytes from B-C ...... ulated by trans-retinoic acid.

@en

prefLabel

Vdelta1 T lymphocytes from B-C ...... ulated by trans-retinoic acid.

@en

P1433

Q40479856-5DD433FC-7D71-436E-ABD7-B6972EB46229

P1476

Q40479856-3DB714D5-FC37-4BA7-B3FF-AEE6AF3370D9

P2093

Q40479856-1148C674-2C78-427E-B957-ED7FD732081C

Q40479856-2A13D51F-C602-48E7-B769-331F0B711816

Q40479856-5418E703-0EA5-4D18-B6A1-A82EE9B7C07C

Q40479856-B599EBA9-8B9F-45CC-847B-184CF6711456

Q40479856-B9CFC111-BDFE-4838-83CA-36F98E8D9ADC

Q40479856-BD58D8C8-0021-4A53-BDAF-C754B81DCEF4

Q40479856-EB1209AB-80D3-4240-A845-CF81562FB4A5

Q40479856-ECE8337E-337A-45F1-9061-6762362AAD2E

P304

Q40479856-D63C3B43-4194-4A6B-8817-22BAAE8E6DAD

P31

Q40479856-E26CAFCB-0EEC-4378-8078-4381F88018E9

P356

Q40479856-3B11A263-52B3-4A8B-A8AB-F1D79E6895BC

P407

Q40479856-29EB210F-924A-4B44-A1AC-9011208DC73A

P433

Q40479856-486E909F-7712-4CDE-83F4-F6C677F36B73

P478

Q40479856-4AD78973-9559-4D73-A117-257F4416BDCA

P50

Q40479856-60AAA0FB-FB0C-4557-9AA0-34B9842A5A8A

Q40479856-9E30A5C3-A6D4-4BA6-9991-81590173AEB7

Q40479856-EC72DC3C-99EB-479F-AED7-E433BDF599C8

P577

Q40479856-482D4C09-69D5-427F-8379-DDE3E430639C

P698

Q40479856-98485B3E-43EF-4646-BD7E-D3E166E9024C

P921

Q40479856-2811FC0F-E74E-46D0-ABB8-449D3FD84178

Q40479856-9D8FA66A-D805-4AF6-8CDD-115D674C1385

P356

0008-5472.CAN-04-2417

P1433

Cancer Research

P1476

Vdelta1 T lymphocytes from B-C ...... ulated by trans-retinoic acid.

@en

P2093

Alessandro Poggi

http://www.w3.org/2001/XMLSchema#string

Claudia Venturino

http://www.w3.org/2001/XMLSchema#string

Federico Caligaris-Cappio

http://www.w3.org/2001/XMLSchema#string

Marco Gobbi

http://www.w3.org/2001/XMLSchema#string

Marino Clavio

http://www.w3.org/2001/XMLSchema#string

Maurizio Miglino

http://www.w3.org/2001/XMLSchema#string

Silvia Catellani

http://www.w3.org/2001/XMLSchema#string

Stefania Stella

http://www.w3.org/2001/XMLSchema#string

P304

9172-9179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-04-2417

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Steinle

Maria R. Zocchi

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15604289

http://www.w3.org/2001/XMLSchema#string

P921